Drug Information

Drug General Information
Drug ID
D0R1FR
Former ID
DNC014131
Drug Name
(3R)-9-amino-3-methyl-1,2,3,4-tetrahydroacridine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530551]
Formula
C14H16N2
Canonical SMILES
CC1CCC2=C(C3=CC=CC=C3N=C2C1)N
InChI
1S/C14H16N2/c1-9-6-7-11-13(8-9)16-12-5-3-2-4-10(12)14(11)15/h2-5,9H,6-8H2,1H3,(H2,15,16)/t9-/m1/s1
InChIKey
WVQOYPIATZDPLZ-SECBINFHSA-N
PubChem Compound ID
11275885
Target and Pathway
Target(s) Acetylcholinesterase Target Info Inhibitor [530551]
KEGG Pathway Glycerophospholipid metabolism
Cholinergic synapse
PANTHER Pathway Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database ATF-2 transcription factor network
PathWhiz Pathway Phospholipid Biosynthesis
WikiPathways Monoamine Transport
Biogenic Amine Synthesis
Acetylcholine Synthesis
Integrated Pancreatic Cancer Pathway
References
Ref 530551Eur J Med Chem. 2010 Feb;45(2):526-35. Epub 2009 Nov 10.Synthesis and AChE inhibitory activity of new chiral tetrahydroacridine analogues from terpenic cyclanones.
Ref 530551Eur J Med Chem. 2010 Feb;45(2):526-35. Epub 2009 Nov 10.Synthesis and AChE inhibitory activity of new chiral tetrahydroacridine analogues from terpenic cyclanones.